VALIANTLAB
Valiant Laboratories Limited (VALIANTLAB) Stock Analysis
Valiant Laboratories Limited manufactures pharmaceutical APIs and intermediates for anti-infectives and other therapies. It supplies bulk actives to formulation makers in India and abroad from Gujarat facilities. The company is a listed API manufacturer on Indian exchanges.
Healthcare › Drug Manufacturers - Specialty & Generic
₹119.80
-4.22% 1W | +41.70% 52W
Market Cap
651 CR
P/E Ratio
42.6
52W High
₹132.2
52W Low
₹49.5
Div. Yield
0%
Beta
0.9
50 DMA
₹100.6
200 DMA
₹74.1
Profit Margin
5.2%
Inst. Own.
0%
⚠️ BREAKDOWN
⚠️ BREAKDOWN
Fundamentals
Profit & Loss
| Metric | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 51 | 60 | 41 | 31 | 19 | 21 | 35 | 58 | 47 | 46 | 52 | 92 | 115 |
| Expenses | 48 | 61 | 47 | 35 | 21 | 28 | 35 | 54 | 44 | 46 | 53 | 87 | 86 |
| Operating Profit | 4 | -1 | -6 | -5 | -2 | -7 | 1 | 4 | 2 | 0 | -1 | 5 | 29 |
| OPM % | 7% | -2.3% | -16% | -15% | -13% | -31% | 1.8% | 7% | 5% | 0.2% | -1.7% | 5% | 25% |
| Other Income | 2 | 3 | 2 | 2 | 3 | 3 | 2 | -2 | 1 | 1 | 1 | 0 | 1 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
| Depreciation | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 3 | 3 |
| Profit before tax | 6 | 1 | -5 | -3 | -0 | -4 | 2 | 1 | 2 | 0 | -3 | 1 | 26 |
| Tax % | 26% | 25% | -31% | -52% | 219% | 21% | -44% | 26% | 26% | 25% | 136% | -68% | 19% |
| Net Profit | 4 | 1 | -4 | -1 | -1 | -5 | 2 | 1 | 2 | 0 | -7 | 2 | 21 |
| EPS in Rs | 1.05 | 0.19 | -0.64 | -0.23 | -0.09 | -0.87 | 0.43 | 0.13 | 0.34 | 0.04 | -1.30 | 0.32 | 3.88 |
| Metric | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|
| Sales | 334 | 182 | 133 | 237 | 306 |
| Expenses | 299 | 190 | 138 | 231 | 273 |
| Operating Profit | 35 | -8 | -5 | 6 | 33 |
| OPM % | 11% | -4.6% | -3.5% | 2.7% | 11% |
| Other Income | 5 | 10 | 5 | 2 | 3 |
| Interest | 0 | 0 | 0 | 2 | 3 |
| Depreciation | 2 | 2 | 2 | 6 | 8 |
| Profit before tax | 38 | -1 | -2 | 1 | 25 |
| Tax % | 24% | -142% | 46% | 525% | |
| Net Profit | 29 | 0 | -2 | -3 | 16 |
| EPS in Rs | 7.13 | 0.06 | -0.41 | -0.60 | 2.94 |
| Dividend Payout % | 0% | 0% | 0% | 0% |
Growth — CAGR
| Metric | 3Y | 5Y | 10Y |
|---|---|---|---|
| Revenue CAGR | -11.0% | – | – |
Shareholding Pattern
Promoters74.94%
FIIs0.63%
DIIs0.46%
Public23.97%
Promoters74.94%
FIIs0.02%
Public25.05%
Promoters74.94%
FIIs0.01%
Public25.05%
Promoters74.94%
FIIs0.20%
Public24.87%
Promoters74.94%
Public25.06%
Promoters74.94%
FIIs3.48%
Public21.58%
Promoters74.94%
FIIs0.64%
Public24.42%
Promoters74.94%
FIIs0.20%
Public24.87%
Promoters74.94%
Public25.06%
VALIANTLAB
Holdings Analysis
Key strengths & risk signals
60
Overall
47
Fundamental
74
Technical
Risks (2)
Cannot calculate PEG - insufficient growth data.
WEAK MOMENTUM! Limited price growth - -4.2% (1 week), -0.0% (1 month), 93.0% (3 months).
Strengths (4)
MODERATE STABILITY! 2 revenue dips in history. Acceptable but monitor closely.
BULLISH TREND! 50-day average (100.6) is above 200-day average (74.1) - positive signal.
GOOD YEAR! Stock gained 41.7% in the last year.
STRONG! Trading at 85.0% of 52W range - near yearly highs.
Fundamental & Technical Analysis
60Overall
47Fundamental
74Technical
Fundamental Breakdown
Growth Quality
4/30
Revenue CAGR: -10.7% (DECLINING, 2/15). Profit CAGR: 0% (DECLINING, 2/15).
Profit Margin
3/10
LOW MARGIN! 5.2% profit margin - thin profits.
PEG Valuation
1/10
Cannot calculate PEG - insufficient growth data.
Dividend Yield
3/10
NEGLIGIBLE DIVIDEND! 0% yield - little to no income.
Debt to Equity
10/10
VERY LOW DEBT! D/E of 0.00 - excellent financial health.
Public Holding
20/20
VERY LESS PUBLIC HOLDING! 14.66% public ownership - strong promoter/institutional control.
Stability Index
6/10
MODERATE STABILITY! 2 revenue dips in history. Acceptable but monitor closely.
Technical Breakdown
Moving Averages
12/10
BULLISH TREND! 50-day average (100.6) is above 200-day average (74.1) - positive signal.
Price Position
8/10
STRONG POSITION! Current price (119.8) is above both moving averages.
Trend Pattern
10/20
BREAKDOWN! Stock has broken below support levels - weakness present.
52W Performance
10/10
GOOD YEAR! Stock gained 41.7% in the last year.
Volume Sentiment
20/30
BULLISH SENTIMENT! In last 30 days: 16 up days, 14 down days. Avg volume on up days: 132,221 vs down days: 121,148. Ratio: 1.09x
RSI
3/5
NEUTRAL! RSI at 55.5 - balanced momentum.
52W Range
5/5
STRONG! Trading at 85.0% of 52W range - near yearly highs.
Momentum
2/5
WEAK MOMENTUM! Limited price growth - -4.2% (1 week), -0.0% (1 month), 93.0% (3 months).
Beta
4/5
BELOW MARKET! Beta of 0.90 - slightly less volatile than market.
Peer Comparison
Healthcare · Drug Manufacturers - Specialty & Generic · 8 stocks
| Stock | Price | P/E | Profit Margin | Revenue CAGR 5Y | Profit CAGR 5Y | 52W Change | Stock Strength | Trendline | YoY Profit | QoQ Profit | YoY Revenue | QoQ Revenue |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| VALIANTLAB | ₹119.80 | 42.6 | 5.2% | -10.7% | – | +41.7% | 60 | BREAKDOWN | +1,072.2% | +1,072.2% | +146.4% | +25.3% |
| WANBURY | ₹196.40 | 12.1 | 8.6% | 8.9% | – | -21.7% | 51 | APPROACHING SUPPORT | -76.3% | -85.3% | +1.5% | +0.6% |
| AMANTA | ₹187.40 | 45.1 | 5.0% | 3.3% | – | +54.5% | 61 | BREAKDOWN | -5.7% | -40.0% | +5.4% | -10.6% |
| ZIMLAB | ₹150.50 | 183.5 | 0.9% | -2.5% | -37.9% | +105.9% | 57 | APPROACHING RESISTANCE | +110.5% | -208.1% | +31.2% | -10.5% |
| ANUHPHR | ₹82.00 | 18.6 | 5.7% | 13.5% | 4.3% | +4.0% | 64 | BREAKDOWN | +37.3% | -2.6% | +3.9% | -4.1% |
| KILITCH | ₹241.60 | 27.4 | 12.7% | 19.2% | 42.4% | +41.9% | 84 | BREAKOUT | -3.3% | -80.0% | +4.2% | -49.9% |
| ALBERTDAVD | ₹791.60 | 20 | 6.2% | -1.1% | – | +1.3% | 51 | BREAKDOWN | +305.1% | -249.5% | +43.5% | +17.9% |
| MEDICAMEQ | ₹300.90 | 40.6 | 4.7% | 12.0% | -13.4% | +1.1% | 54 | BREAKDOWN | -4.5% | -46.2% | +11.4% | -21.0% |
Data from TradeAlone · Updated daily
